Silvers Jason
SEC insider (Form 3/4/5 filer). CIK 0002109011. President & CFO at Generate Biomedicines, Inc. (GENB). 5 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in SOMERVILLE, MA.
Companies Silvers Jason has filed insider reports for
- Generate Biomedicines, Inc. (GENB): Officer, President & CFO
Silvers Jason
CIK: 0002109011
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Generate Biomedicines, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Mar 2, 2026GENB
Generate Biomedicines, Inc.
PurchaseIndirect500 shares at avg. $16.00$8K - Mar 2, 2026GENB
Generate Biomedicines, Inc.
PurchaseIndirect500 shares at avg. $16.00$8K - Mar 2, 2026GENB
Generate Biomedicines, Inc.
PurchaseIndirect1K shares at avg. $16.00$16K - Feb 26, 2026GENB
Generate Biomedicines, Inc.
AwardDirectStock Option (Right to Buy)
295.6K shares- - Feb 26, 2026GENB
Generate Biomedicines, Inc.
AwardDirectStock Option (Right to Buy)
274.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 | GENB Generate Biomedicines, Inc. | Purchase | 500 | $16.00 | $8,000 | Indirect |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc. | Purchase | 500 | $16.00 | $8,000 | Indirect |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc. | Purchase | 1,000 | $16.00 | $16,000 | Indirect |
| Feb 26, 2026 | GENB Generate Biomedicines, Inc. | Award Stock Option (Right to Buy) | 295,608 | - | - | Direct |
| Feb 26, 2026 | GENB Generate Biomedicines, Inc. | Award Stock Option (Right to Buy) | 274,493 | - | - | Direct |
1-5 of 5 transactions